This year’s Fortune 500 saw several pharmaceutical companies climbing the ranks, while some experienced exponential growth. Gilead, for example, grew by almost 5000%. Surprisingly, this wasn’t enough for it to maintain its spot, falling from no. 116 to 123. In contrast, Pfizer climbed up an […]
Pharmaceutical Compliance Congress Canada 2022
Taking place in Toronto, ON from June 7-9, the Pharmaceutical Compliance Congress Canada is the leading conference in Canada for life sciences ethics and compliance professionals. The event allows industry professionals to connect with their colleagues through panel discussions, case studies, talks […]
Syndicated Report: Real World Evidence Solutions Market Size, Trends and Forecast to 2029
The real-world evidence (RWE) landscape has been jump-started in the past few years, in part due to the COVID-19 pandemic. A new syndicated report by Verified Market Research explores the projected growth of the RWE solutions market in clinical settings data, patient-powered data, pharmacy data and […]
Submit Your Nomination for the 2022: Fierce Biotech Fierce 15
Fierce Biotech is seeking your nominations for the 2022: Fierce Biotech Fierce 15. Every year, Fierce Biotech’s readers nominate their pics for the newest and most promising privately-owned biotechs across all therapeutic areas. Fierce Biotech will accept nominations until Friday, July […]
Exploring Climate Change Through the Lens of Health Equity
The effects of climate change disproportionately impact marginalized populations and countries with developing economies. As a result, people within these regions and populations bear the brunt of climate change-related health disparities. In a new article published by the Kaiser Family Foundation, […]
On-Demand Webinar: Navigating the Path to the Clinic And Beyond For Gene Therapies
Bringing novel gene therapies from the drawing board to patients requires careful consideration of each step of the pipeline. A key component is developing manufacturing processes that can pass the requirements of regulatory agencies. Additionally, biotechs must consider the logistics of bringing […]
Webinar: Accelerating Patient Recruitment in Clinical Trials Post COVID-19
Patient recruitment can make or break a clinical trial. Unfortunately, it is also one of the most difficult problems facing clinical researchers. The situation has been complicated by the COVID-19 pandemic. These challenges and possible paths forward will be discussed in a an upcoming webinar by […]
Bavarian Nordic in Talks with Governments to Produce Monkeypox Vaccines
As more cases of monkeypox spring up across the world, the German government has ordered 40,000 doses of monkeypox vaccines from Bavarian Nordic. The vaccine manufacturer said that it is in talks with several world governments, each looking to vaccinate vulnerable populations and build its […]
The Post-Pandemic Outlook for EMRs
The COVID-19 pandemic exposed numerous inefficiencies and points of improvement in several aspects of the healthcare system, including electronic medical records (EMRs). These changes could not be fully implemented at the time, but as the pandemic seemingly winding down, market research shows that […]
Streamlining Drug Development and Manufacturing with End-to-End CDMO Partnerships
Efficiently developing drugs and getting them to patients requires careful optimization of drug development, manufacturing, and supply processes. Small to mid-size companies may struggle to synchronize the process efficiently, especially with uncertainty and disruption from tumultuous current […]
The Importance of Integrated Service Offerings in Biopharma
Smaller biotechs have pivoted in recent years from selling products early in the development cycle to holding onto their assets. However, managing every stage of the development process is beyond the reach of many firms. In a recent Drug Discovery Online article, David K. Lyon, Ph.D, of Lonza […]
Diabetes, Psoriasis, and Arthritis are Top Drug Categories for Ad Spending
Research from MediaRadar has identified diabetes as the largest therapy area for pharma direct-to-customer (DTC) advertising spending in 2021. Also in the top five are psoriasis, arthritis, HIV/AIDs, and breast cancer. Approximately $777 million was spent on ads for diabetes medicines and devices […]
Developing a Resilient Patient-Centered Clinical Supply Chain
As clinical trials grow in complexity, the need for resilient supply chains is increasingly apparent. The industry is responding by developing flexible new strategies like direct-to-patient distribution and demand-led supply. In a recent Clinical Leader Article by Catalent, these new options and […]
Alcon Purchases Dry Eye Medication from Kala Pharmaceuticals
The vision care company Alcon is moving into the dry eye disease market with its purchase of two medications from Kala Pharmaceuticals. Kala sold its dry-eye drug Eysuvis and post-operative ocular pain drug Inveltys to Alcon for $60 million upfront, alongside future milestone payments. The two drugs […]
Driving HCP Engagement with AI and RWD
Artificial intelligence (AI) and real-world data (RWD) are beginning to be leveraged by marketers in medtech industries. However, fully taking advantage of these tools requires a defined understanding of the questions asked and the data sources used. A new MedTech Dive article explains how a […]
The Effects of Social Ties on Latinx Health Outcomes
Chronic stress caused by social discrimination can negatively impact the health of marginalized communities. However, the social ties within a community can help reduce the impact of stress and reduce inflammatory biomarkers associated with negative health outcomes. Researchers from the University […]
Over 120 Deaths and 21,000 Complaints Accrue in Year after Philips’ Ventilator Foam Recall
Last April, Philips reported quality issues in the sound-reducing foam used in many respiratory aids, including ventilators, CPAP, and BiPAP machines. The US Food and Drug Administration (FDA) has just released a one-year update about the issue, finding that the deterioration of the foam resulted in […]
Value in Health Regional Issues: Cost-Effectiveness of Novel Kidney Disease Biomarker Screening
IgA nephropathy (IgAN) is a leading cause of end-stage kidney disease across the world. A new paper in Value in Health Regional explores the cost-effectiveness of screening for IgAN in Japan using novel biomarkers. Using an analytical decision model, researchers found that screening could […]
Looking Into the Future of Life Sciences Industry
The life sciences industry’s impressive response to the COVID-19 was made possible by unprecedented collaboration between the pharmaceutical, medical diagnostics, and medical devices industries. This spurred a massive influx of capital that is still buoying the market, despite recent bumps and […]
Early-Stage Biopharma Financing in 2022
In an article from earlier this year, Richard Ramko of Life Science Leader laid out the current landscape of early-stage biopharma financing. The unprecedented levels of investments throughout 2020 and early 2021 began to dip in the latter half of the year and early 2022. However, Ramko argues that […]
European Medicines Agency Recommends Suspension of 100 Drugs Due to CRO Data Concerns
Data integrity issues at Synchron Research Services spurred the European Medicines Agency to recommend the suspension of 100 drugs. Synchron, an India-based CRO, runs quality control tests for generics from several manufacturers. The firm has faced similar critiques from the US Food and Drug […]
Top Pharma Companies Form Coalition to Increase Access to Cancer Therapies in Developing Countries
Less than half of the cancer therapies deemed essential by the World Health Organization are available in low- and lower-middle-income countries (LLMICs). The newly formed Access to Oncology Medicines (ATOM) Coalition seeks to address this issue. The coalition, led by the Union for International […]
Draft CADTH Recommendation for Spinraza™ (nusinersen) Fails Adults in Need of Treatment for Spinal Muscular Atrophy (SMA)
CADTH does not accept new evidence demonstrating SPINRAZA™'s effectiveness and safety for treating SMA – a progressive, life-altering neurodegenerative disease SMA treatment access remains unequal across Canada , with only Quebec funding SMA care for patients over 18 Implementing the draft […]
Global Vital Signs Monitoring Devices Market Size is Estimated to Reach USD 8,126.0 Million by 2030, at a CAGR of 5.8%: Astute Analytica
NEW DELHI , May 20, 2022 /PRNewswire/ -- The study undertaken by Astute Analytica foresees a tremendous growth in revenue of the market for global vital signs monitoring devices market from US$ 4,960.0 Million in 2021 to US$ 8,126.0 Million by 2030. The market is anticipated to grow at a CAGR of […]
Bayer Backs Out of Atara CAR-T Partnership
Following a pause in a CAR-T cell mesothelioma therapy caused by a patient death, Bayer has pulled out of a $670 million partnership with Atara. The two partnered to advance two therapeutic candidates through clinical and pre-clinical development, with Bayer paying Atara $60 million upfront. The […]
Voluntary Recall Guidance Released by FDA
The US Food and Drug Administration (FDA) issued its final guidance in April on initiating voluntary recalls for drugs, biologics, and medical devices. Although largely in line with the previous draft guidance issued in April 2019, the agency made changes based on public comments. The non-binding […]
Pfizer and Headlands Health Partner to Increase Clinical Trial Diversity
Clinical trial participants are often far less diverse than the populations they represent, as clinical trial sites are often located in wealthier urban areas. To help solve this problem, Pfizer and Headlands Research have partnered to initiate research sites in more diverse areas. The first such […]
Gilead Places Restrictions on 340B Drug Pricing for Hepatitis C Treatments
The drugmaker Gilead cut off 340B discounts for certain hepatitis C drugs to some hospitals if they do not provide claims data to their specifications. The drugs, which include Epclusa, Solvadi, Vosevi, and Harvoni, previously qualified for 340B pricing discounts, but the manufacturer accuses […]
Webinar – May 21st – Addressing the Intersection Between LGBTQ+ and Parkinson’s Disease Communities
LGBTQ+ identity is a social determinant of health (SODH) associated with limited access to healthcare and worse health outcomes. In an upcoming online symposium hosted in coordination between the Parkinson’s Foundation and the Medical College of Georgia, the intersection of LGBTQ+ identity and […]
AJMC Video: Dr Miruna Sasu Discusses the Transformative Power of Real-world Data
In a new video interview from AJMC, Miruna Sasu PhD, President and CEO of COTA Healthcare explains how real-world data (RWD) can empower the drug discovery and development processes. RWD can be used in tandem with wet-lab data to help propel drug candidate or biomarker identification. Once a […]
